Oncotelic Therapeutics's total assets for Q3 2025 were $28.16M, an increase of 5.53% from the previous quarter. OTLC total liabilities were $20.08M for the fiscal quarter, a 4.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.